FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:226-227 July 19, 2001 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

By Trent Stephens and Rock Brynner. 228 pp. Cambridge, Mass., Perseus, 2001. $26. ISBN 0-7382-0404-8.

Some drugs have become household names — penicillin, insulin, aspirin. Most are known — indeed, revered — as lifesavers. Thalidomide, too, falls into the category of well-known drugs, but for an entirely different reason. As a medicine that maimed rather than saved, it had atrocious effects on the unborn child that make it an object of terror and horror.

Thalidomide appeared in the late 1950s — a decade of optimism about therapies, fueled largely by the success of penicillin during the Second World War. Postwar Western society was essentially at peace with the great infectious diseases, thanks to vaccines and . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.